Skip to main content

PepGen Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

PEPG$4.61+92.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OFCASH FLOWS

(IN THOUSANDS)

Six Months EndedJune 30,
20262025
Cash flows from operating activities:
Net loss$(35,575)$(53,289)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation572722
Stock-based compensation expense6,1685,795
Amortization and interest accretion related to operating lease1,8741,874
Amortization of premiums and accretion of discounts on marketable securities, net(1,714)(1,150)
Impairment of long-lived assets—701
Changes in operating assets and liabilities:
Prepaids and other current and non-current assets(217)737
Accounts payable229(885)
Accrued expenses and other non-current liabilities(3,991)496
Operating lease liabilities, current and non-current(1,578)(1,532)
Net cash used in operating activities$(34,232)$(46,531)
Cash flows from investing activities:
Purchases of property and equipment(30)(168)
Purchases of marketable securities(81,945)(6,726)
Maturities of marketable securities77,00039,000
Net cash (used in) provided by investing activities(4,975)32,106
Cash flows from financing activities:
Issuance of common stock from At-the-Market Sales Agreement, net of underwriters' fees1,511—
Payment of offering costs(175)—
Proceeds from employee equity plans11798
Net cash provided by financing activities$1,453$98
Effect of exchange rate changes on cash4(22)
Net decrease in cash, cash equivalents and restricted cash$(37,750)$(14,349)
Cash, cash equivalents and restricted cash at beginning of period62,06250,969
Cash, cash equivalents and restricted cash at end of period$24,312$36,620
Components of cash, cash equivalents and restricted cash
Cash and cash equivalents$22,764$35,072
Restricted cash1,5481,548
Total cash, cash equivalents and restricted cash at end of period$24,312$36,620
Supplemental noncash investing and financing activities
Cash paid for taxes$49$86
Property and equipment included in accounts payable and accrued expenses—27
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.